Capsular expression in Streptococcus pneumoniae negatively affects spontaneous and antibiotic-induced lysis and

Jenny Fernebro1, Ingrid Andersson, Jack Sublett

  • 1Department of Molecular Epidemiology and Biotechnology, Smittskyddsinstitutet, Solna, Stockholm, Sweden.

Insights

Capsular polysaccharides in Streptococcus pneumoniae reduce antibiotic-induced lysis and increase tolerance. Loss of capsule expression, particularly mutations in the cps9vE gene, restores bacterial lysis and antibiotic susceptibility.

Area of Science:

  • Microbiology
  • Bacterial Pathogenesis
  • Antibiotic Resistance

Background:

  • Streptococcus pneumoniae employs the N-acetylmuramyl-l-alanine amidase LytA for antibiotic-induced lysis.
  • Clinical isolates exhibit variable lytic responses to penicillin and vancomycin, influenced by capsular serotypes.

Purpose of the Study:

  • To investigate the role of capsular polysaccharides in Streptococcus pneumoniae's response to antibiotics.
  • To determine the impact of capsule expression on antibiotic tolerance and bacterial lysis.

Main Methods:

  • Comparative analysis of lytic responses in clinical isolates and parent-mutant pairs with varying capsule expression.
  • Genetic sequencing of capsular locus (cps9vE) in antibiotic-tolerant and lytic mutants.
  • Assessment of autolysis and LytA activity in encapsulated and non-encapsulated strains.

Main Results:

  • Non-encapsulated pneumococcal variants demonstrated significantly higher lysis upon treatment with beta-lactam and/or vancomycin.
  • Antibiotic tolerance was exclusively observed in encapsulated strains, requiring an intact lytA autolysin gene for lysis.
  • Mutations within the cps9vE gene were identified as a hot spot, leading to loss of capsule and restored antibiotic susceptibility.

Conclusions:

  • Capsular polysaccharides negatively regulate the lytic process in Streptococcus pneumoniae.
  • Capsule expression is a critical factor contributing to antibiotic tolerance in clinical pneumococcal isolates.
  • Targeting capsule synthesis or related genes could be a strategy to overcome antibiotic tolerance.

Related Concept Videos

Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...